Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Synthetic Printed Implants Prompt Spinal Regeneration in Model

By LabMedica International staff writers
Posted on 31 Jan 2019
The potential use of three-dimensional (3D) printing to produce replacement components for the repair of spinal damage was demonstrated in a rat model system.

Up to now, three-dimensional printing of central nervous system (CNS) structures has not been accomplished, possibly owing to the complexity of CNS architecture. More...
To rectify this situation, investigators at the University of California, San Diego (USA) used a three-dimensional microscale continuous projection printing method (MuCPP) to create a complex CNS structure for regenerative medicine applications in the spinal cord.

The MuCPP method enabled printing of three-dimensional biomimetic hydrogel scaffolds that were tailored to the dimensions of the rodent spinal cord. This process required only 1.6 seconds and was scalable to human spinal cord sizes and lesion geometries. In this regard, four-centimeter-sized implants modeled from MRI scans of actual human spinal cord injuries were printed within 10 minutes. The printed scaffolds contained dozens of 200-micrometer-wide channels that guided neural stem cell and axon growth along the length of the spinal cord injury.

The investigators tested the ability of MuCPP three-dimensional-printed scaffolds loaded with neural progenitor cells (NPCs) to support axon regeneration and form new "neural relays" across sites of complete spinal cord injury in vivo in rodents.

They reported in the January 14, 2019, online edition of the journal Nature Medicine that injured host axons regenerated into three-dimensional biomimetic scaffolds and synapsed onto NPCs implanted into the device. Implanted NPCs in turn extended axons out of the scaffold and into the host spinal cord below the injury to restore synaptic transmission and significantly improve the animal's ability to move.

"In recent years and papers, we have progressively moved closer to the goal of abundant, long-distance regeneration of injured axons in spinal cord injury, which is fundamental to any true restoration of physical function," said senior author Dr. Mark Tuszynski, professor of neuroscience at the University of California, San Diego.

Related Links:
University of California, San Diego


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.